Sign inJoin waitlistJoin the waitlist

Meghan Karuturi

Associate Professor, Breast Medical Oncology · University of Texas M D Anderson Cancer Center

Credentials: · · · · ·

History

University of Texas M D Anderson Cancer Center
Present

University of Texas M D Anderson Cancer Center
2011–2014
Hospital of the University of Pennsylvania
2008–2011
George Washington Univ Sch of Med
2004–2008

Research

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
Nature Communications · 2017 · 247 citations
Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review
Review · JAMA Oncology · 2017 · 178 citations
Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2- Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)
Clinical Cancer Research · 2021 · 113 citations

Gretchen Kimmick
11 papers
Hyman Muss
9 papers
JB
Joanne Blum
8 papers
Sharon Giordano
8 papers
Gabrielle Rocque
7 papers
JS
Joellen Speca
7 papers
Lisa Carey
7 papers
Raquel Reinbolt
7 papers
Trevor Jolly
7 papers
DT
Debasish Tripathy
6 papers
Elizabeth Dees
6 papers
Holly Holmes
6 papers

Grants

Developing a Decision Tool for Chemotherapy in Older Women with Early Stage Breast Cancer
National Cancer Institute · K08
Contact PI · $1.3M · University of Tx Md Anderson Can Ctr
2019–2026

Clinical trials

Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Principal investigator · Terminated
M.D. Anderson Cancer Center
2022–2024
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment
Principal investigator · Active not recruiting
M.D. Anderson Cancer Center
2021–2027
Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial
Principal investigator · Withdrawn · Phase 1
M.D. Anderson Cancer Center
2021–2022
Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer
Principal investigator · Active not recruiting
M.D. Anderson Cancer Center
2020–2026